reAlpha Tech vs CaliberCos
AIRE and CWD side by side, both in real estate. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AIRE and CWD compare
CaliberCos is the larger company, worth 1.6 times as much as reAlpha Tech ($3.8M against $2.3M).
CaliberCos keeps more of each dollar of sales as profit, with a net margin of −117% compared with −339% at reAlpha Tech.
reAlpha Tech scores higher on the StockData Score (4 against 1 for CaliberCos), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AIRE | CWD |
|---|---|---|
| Size and price | ||
| Market cap | $2.3M | $3.8M |
| Share price | $0.389 | $0.363 |
| Change, 1 year | −96.7% | −84.5% |
| Beta (5Y) | 3.03 | 2.62 |
| Employees | 54 | – |
| StockData Score | ||
| Total score | 4 (better) | 1 |
| Valuation score | 1 | 1 |
| Growth score | 0 | 0 |
| Performance score | 0 | 0 |
| Health score | 3 (better) | 0 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 0.5× | 0.2× (better) |
| P/B | 0.7× | – |
| FCF yield | −327% | – |
| Growth | ||
| Revenue growth (TTM) | – | −49.7% |
| Profitability | ||
| Gross margin | 61.5% | – |
| Operating margin | −340% | – |
| Net margin | −339% | −117% (better) |
| FCF margin | −168% | – |
| Return on equity | −211% | – |
| Return on invested capital | −553% | – |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Interest coverage | −190.5× | – |
| Current ratio | 0.48 | – |
| Altman Z-score | −6.41 | −0.57 (better) |
| Piotroski F-score | 5 (better) | 3 |
| Dividends and buybacks | ||
| Buyback yield | −178% | – |
| Shareholder yield | −178% | 0.00% (better) |
| Ownership | ||
| Held by institutions | 4.5% | 2.9% |
| Held by insiders | – | 11.7% |
| Insider net buying, 12 months | −$5.5K | – |
| Short interest, % of float | – | 8.0% |
Go deeper
- AIRE stock overview
- AIRE income statement
- AIRE valuation and score
- CWD stock overview
- CWD income statement
- CWD valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.